{"id":132719,"date":"2026-06-26T16:29:26","date_gmt":"2026-06-26T10:59:26","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=132719"},"modified":"2026-10-07T11:32:38","modified_gmt":"2026-10-07T06:02:38","slug":"sanofi-consumer-healthcare-india-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/sanofi-consumer-healthcare-india-share-price-target-2026\/","title":{"rendered":"Sanofi Consumer Healthcare India Share Price Target 2026: Stock Analysis, Share Price Today, Bull Case and Bear Case After Q2 CY2026"},"content":{"rendered":"
\n

META TITLE:<\/strong> Sanofi Consumer Healthcare India Share Price Target 2026<\/p>\n

META DESCRIPTION:<\/strong> Sanofi Consumer Healthcare India share price target 2026: Rs 3,456 to Rs 4,224 vs Rs 3,736.50. Share price today, stock analysis, buy or sell, bull and bear case.<\/p>\n

SLUG:<\/strong> sanofi-consumer-healthcare-india-share-price-target-2026<\/p>\n

PRIMARY KEYWORD:<\/strong> Sanofi Consumer Healthcare India share price target<\/p>\n

SECONDARY KEYWORDS:<\/strong> Sanofi Consumer Healthcare India share price today, Sanofi Consumer Healthcare India stock analysis, Sanofi Consumer Healthcare India buy or sell, Sanofi Consumer Healthcare India share price forecast, Sanofi Consumer Healthcare India stock price target 2027, Sanofi Consumer Healthcare India price target, Sanofi Consumer Healthcare India buy or sell<\/p>\n

LSI KEYWORDS:<\/strong> analyst consensus, bull case, bear case, 12-month target, PE multiple, EPS estimate, sector tailwinds, institutional holding, resistance level, FY27 outlook<\/p>\n<\/div>\n

Sanofi Consumer Healthcare India Rs 3,736.50 (6 Oct 2026 close). 52-week range Rs 3,691.00 to Rs 5,255.00. Q2 CY2026 revenue Rs 235.7 cr, up 7%; profit Rs 68.8 cr.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The Sanofi Consumer Healthcare India share price target for 2026 is Rs 3,456 to Rs 4,224, which is between 8 percent below and 13 percent above the last close of Rs 3,736.50, with bull and bear cases of Rs 5,100 to Rs 5,700 and Rs 2,310 to Rs 2,835. Sanofi Consumer Healthcare India reported Q2 CY2026 revenue up 7 percent to Rs 235.7 crore, profit before tax up 16 percent to Rs 91.9 crore and profit of Rs 68.8 crore against Rs 60.7 crore, helped by relaunches of Combiflam, Allegra and Depura. Domestic sales grew 12 percent while exports fell 9 percent on a high base, the first-half revenue rose 18 percent, and the stock trades at 32 times earnings against an industry average of 50 times. No brokerage price target was available on the sources we track as of 6 October 2026, so every range below is a Univest research scenario.<\/p>\n<\/p><\/div>\n

The Sanofi Consumer Healthcare India<\/a> share price target for 2026 is Rs 3,456 to Rs 4,224 in the Univest base case, with the stock at Rs 3,736.50 at the 6 October 2026 close. That is 28.9 percent below its 52-week high of Rs 5,255.00 and 1.2 percent above its 52-week low of Rs 3,691.00, and the stock moved down 19.8 percent over the past year. Sanofi Consumer Healthcare India was demerged from Sanofi India and sells Combiflam, Allegra and Depura. Debt to equity is 0.06 and the dividend yield is 2.01 percent. The stock trades on very thin volume.<\/p>\n

Three things changed since the last update: Q2 CY2026 results on 28 July showed profit before tax up 16 percent, the stock has fallen in most weeks since early August, and it hit a 52-week low of Rs 3,691 in the week of 28 September. This Sanofi Consumer Healthcare India stock analysis covers the Sanofi Consumer Healthcare India share price today, the Sanofi Consumer Healthcare India share price target for 2026, 2027 and 2030, the Q2 CY2026 numbers, catalysts and risks, key price levels and a Sanofi Consumer Healthcare India buy or sell view.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n